Envoy Medical, Inc.

Envoy Medical, Inc., trading under the ticker ANZU, is a medical device company focused on hearing health solutions, including fully implantable hearing devices. The company came to market through Anzu Special Acquisition Corp I, sponsored by Anzu Partners LLC, which completed its IPO in 2021 targeting the healthcare and medical technology sector. The November 2022 Form 10-Q filing, carrying accession number 0001104659-22-118526, reflects the company's reporting obligations following its SPAC business combination. Envoy Medical operates in the competitive medical device space, developing solutions aimed at patients with sensorineural hearing loss. For comprehensive filing history, transaction details, and real-time SPAC analytics on Envoy Medical and hundreds of other deals, sign up for full data access at SpacDesk.